Cite
CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability.
MLA
Elzein, Elfatih, et al. “CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability.” Bioorganic & Medicinal Chemistry Letters, vol. 14, no. 24, Dec. 2004, pp. 6017–21. EBSCOhost, https://doi.org/10.1016/j.bmcl.2004.09.077.
APA
Elzein, E., Ibrahim, P., Koltun, D. O., Rehder, K., Shenk, K. D., Marquart, T. A., Jiang, B., Li, X., Natero, R., Li, Y., Nguyen, M., Kerwar, S., Chu, N., Soohoo, D., Hao, J., Maydanik, V. Y., Lustig, D. A., Zeng, D., Leung, K., & Zablocki, J. A. (2004). CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability. Bioorganic & Medicinal Chemistry Letters, 14(24), 6017–6021. https://doi.org/10.1016/j.bmcl.2004.09.077
Chicago
Elzein, Elfatih, Prabha Ibrahim, Dmitry O Koltun, Ken Rehder, Kevin D Shenk, Timothy A Marquart, Bob Jiang, et al. 2004. “CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability.” Bioorganic & Medicinal Chemistry Letters 14 (24): 6017–21. doi:10.1016/j.bmcl.2004.09.077.